PUBLIKACJE ZAKŁAD CHEMII LEKÓW, ANALIZY FARMACEUTYCZNEJ I BIOMEDYCZNEJ ZA ROK 2023
Kocur Arkadiusz, Pawiński Tomasz. Volumetric Absorptive Microsampling in Therapeutic Drug Monitoring of Immunosuppressive Drugs—From Sampling and Analytical Issues to Clinical Application International Journal of Molecular Sciences 2023 IF= 5,6
Kocur Arkadiusz, Rubik Jacek, Czarnowski Paweł, Czajkowska Agnieszka, Marszałek Dorota, Sierakowski Maciej, Górska Marta, Pawiński Tomasz. Therapeutic drug monitoring of mycophenolic acid (MPA) using volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients: ultra-high-performance liquid chromatography-tandem mass spectrometry analytical method development, cross-validation, and clinical application Pharmacological Reports 2023 IF= 4,4
Kocur Arkadiusz, Marszałek Dorota, Rubik Jacek, Czajkowska Agnieszka, Pawiński Tomasz.Therapeutic Drug Monitoring of Tacrolimus Based on Volumetric Absorptive Microsampling Technique (VAMS) in Renal Transplant Pediatric Recipients—LC-MS/MS Method Development, Hematocrit Effect Evaluation, and Clinical Application Pharmaceutics 2023 IF= 5,4
Sobiak Joanna, Żero Paweł, Zachwieja Jacek, Ostalska-Nowicka Danuta, Pawiński Tomasz. Limited sampling strategy to predict free mycophenolic acid area under the concentration–time curve in paediatric patients with nephrotic syndrome Clinical and Experimental Pharmacology and Physiology IF= 2,9
Kózka Bartosz, Sośnicka Agata, Nałęcz-Jawecki Grzegorz, Drobniewska Agata, Turło Jadwiga, Giebułtowicz Joanna. Various species of Basidiomycota fungi reveal different abilities to degrade pharmaceuticals and also different pathways of degradation Chemosphere 2023 IF= 8,8
Stępień Krzysztof, Krawczyk Weronika, Giebułtowicz Joanna. Dietary Supplements with Proline—A Comprehensive Assessment of Their Quality Life 2023 IF= 3,2
Gniazdowska Elżbieta, Giebułtowicz Joanna, Rudzki Piotr. How does the order of sample analysis influence the matrix effect during LC-MS bioanalysis? Journal of Chromatography B 2023 IF= 3
Sobiech Monika, Giebułtowicz Joanna, Luliński Piotr. Computational and experimental studies of magnetic molecularly imprinted sorbent with high specificity towards aceclofenac Microchemical Journal 2023 IF= 4,8
Korytowska-Przybylska Natalia, Michorowska Sylwia, Wyczałkowska-Tomasik Aleksandra, Pączek Leszek, Giebułtowicz Joanna. Development of a novel method for the simultaneous detection of trimethylamine N-oxide and creatinine in the saliva of patients with chronic kidney disease - Its utility in saliva as an alternative to blood Journal of Pharmaceutical and Biomedical Analysis 2023 IF= 3,4
Balcer Emilia, Sobiech Monika, Giebułtowicz Joanna, Sochacka Małgorzata, Luliński Piotr.Molecularly Imprinted Polymers Specific towards 4-Borono-L-phenylalanine—Synthesis Optimization, Theoretical Analysis, Morphology Investigation, Cytotoxicity, and Release Studies Polymers 2023 IF= 5
PUBLIKACJE ZAKŁADU CHEMII LEKÓW ZA ROK 2022
Kucharski Dawid, Stasiuk Robert, Drzewicz Przemysław, Skowronek Artur, Strzelecka Agnieszka, Mianowicz Kamila, Giebułtowicz Joanna.
Fit-for-Purpose Assessment of QuEChERS LC-MS/MS Methods for Environmental Monitoring of Organotin Compounds in the Bottom Sediments of the Odra River Estuary.
Molecules 2022 IF= 4,927
Berdyński Mariusz, Krawczyk Piotr, Safranow Krzysztof, Borzemska Beata, Szaflik Jacek, Nowakowska-Żawrocka Karolina, Żekanowski Cezary, Giebułtowicz Joanna.
Common ALDH3A1 Gene Variant Associated with Keratoconus Risk in the Polish Population.
Journal of Clinical Medicine 2022 IF= 4,964
Sobiech Monika, Synoradzki Karol, Bednarchuk Tamara, Sobczak Kamil, Janczura Marta, Giebułtowicz Joanna, Luliński Piotr.
Impact of structure and magnetic parameters of nanocrystalline cores on surface properties of molecularly imprinted nanoconjugates for analysis of biomolecules – A case of tyramine.
Microchemical Journal 2022 IF= 5,304
Wiśniowska Barbara, Giebułtowicz Joanna, Piotrowski Roman, Kułakowski Piotr, Polak Sebastian.
Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating.
Pharmaceuticals 2022 IF= 5,215
Sośnicka Agata, Kózka Bartosz, Makarova Katerina, Giebułtowicz Joanna, Klimaszewska Marzenna, Turło Jadwiga.
Optimization of White-Rot Fungi Mycelial Culture Components for Bioremediation of Pharmaceutical-Derived Pollutants.
Water 2022 IF= 3,53
Kucharski Dawid, Nałęcz-Jawecki Grzegorz, Drzewicz Przemysław, Skowronek Artur, Mianowicz Kamila, Strzelecka Agnieszka, Giebułtowicz Joanna.
The assessment of environmental risk related to the occurrence of pharmaceuticals in bottom sediments of the Odra River estuary (SW Baltic Sea)
Science of the Total Environment 2022 IF= 10,753
Poznanski Piotr, Giebułtowicz Joanna, Durdzinska Justyna, Kocki Tomasz, Sacharczuk Mariusz, Bujalska-Zadrożny Magdalena, Leśniak Anna.
Mechanisms Underlining Inflammatory Pain Sensitivity in Mice Selected for High and Low Stress-Induced Analgesia—The Role of Endocannabinoids and Microglia.
International Journal of Molecular Sciences 2022 IF= 6,208
Stępień Krzysztof, Giebułtowicz Joanna.
Application of Liquid Chromatography Coupled to Mass Spectrometry in Quality Assessment of Dietary Supplements—A Case Study of Tryptophan Supplements: Release Assay, Targeted and Untargeted Studies.
Pharmaceuticals 2022 IF= 5,215
Sobiech Monika, Giebułtowicz Joanna, Woźnica Marcin, Jaworski Igor, Luliński Piotr.
Theoretical and experimental model of molecularly imprinted polymer surface microenvironment for selective stationary phase – Exemplary of S-pramipexole for potential pharmaceutical analysis.
Microchemical Journal 2022 IF= 5,304
Sankowski Bartłomiej, Michorowska Sylwia, Raćkowska Emilia, Sikora Mariusz, Giebułtowicz Joanna.
Saliva as Blood Alternative in Therapeutic Monitoring of Teriflunomide—Development and Validation of the Novel Analytical Method.
International Journal of Molecular Sciences 2022 IF= 6,208
Lisowska-Myjak Barbara, Zborowska Hanna, Białek Sławomir, Wroczyński Piotr, Kuch Marek, Skarżyńska Ewa.
Exploring associations of anthropometric parameters and serum triglycerides with serum thyroid hormones in young women.
Scientific Reports 2022 IF= 4,996
Yadav Jyoti, Żołek Teresa, Maciejewska Dorota, Gilant Edyta, Gniazdowska Elżbieta, Kutner Andrzej, Noworyta Krzysztof, Kutner Włodzimierz.
Polytyramine film-coated single-walled carbon nanotube electrochemical chemosensor with molecularly imprinted polymer nanoparticles for duloxetine-selective determination in human plasma.
ACS Sensors 2022 IF= 9,618
Żołek Teresa, Yasuda Kaori, Brown Geoffrey, Sakaki Toshiyuki, Kutner Andrzej.
In silico prediction of the metabolic resistance of vitamin D analogs against CYP3A4 metabolizing enzyme.
International Journal of Molecular Sciences 2022 IF= 6,208
Jyoti, Rybakiewicz-Sekita Renata, Żołek Teresa, Maciejewska Dorota, Gilant Edyta, Buś-Kwaśnik Katarzyna, Kutner Andrzej, Noworyta Krzysztof, Kutner Włodzimierz.
Cilostazol-imprinted polymer film-coated electrode as an electrochemical chemosensor for selective determination of cilostazol and its active primary metabolite.
Journal of Materials Chemistry B 2022 IF= 7,571
Kocur Arkadiusz, Kunicki Paweł, Pawiński Tomasz.
Generic medicinal products in immunosuppressive therapy – should it be a challenge for therapeutic drug monitoring?
Therapeutic Drug Monitoring 2022 IF= 3,118
Bodnar-Broniarczyk Magdalena, Warzyszyńska Karola, Czerwińska Katarzyna, Marszałek Dorota, Dziewa Natalia, Kosieradzki Maciej, Pawiński Tomasz.
Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients.
Pharmaceutics 2022 IF= 6,525
Lemaitre Florian, Budde Klemens, Van Gelder Teun, Bergan Stein, Lawson Roland, Noceti Ofelia, Venkataramanan Raman, Elens Laure, Moes Dirk Jan A.R., Hesselink Dennis A., Pawiński Tomasz, Johnson-Davis Kamisha L., De Winter Brenda C.M., Pattanaik Smita, Brunet Merce, Masuda Satohiro, Langman Loralie J..
Therapeutic Drug Monitoring and dosage adjustments of immunosuppressive drugs when combined with nirmatrelvir/ritonavir in patients with COVID-19.
Therapeutic Drug Monitoring 2022. IF= 3,118